Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-14-058292

Director sold 41,500 shares at $0.23 ($9,358)

  • Director acquired 41,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kraus Al Director 2014-09-25 Option exercise +41,500 $0.04 $1,453 1,435,131 D: show line 1 in the form
Kraus Al Director 2014-09-25 Sale −41,500 $0.23 $9,358 1,393,631 D: show line 2 in the form
Open-market sales · 41,500 sh · avg $0.23 · $9,358

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Kraus Al Director 2014-09-25 Option exercise · Stock Option −41,500 6,169,328 D: show line 3 in the form
Loading xslF345X03/v390227_4.xml…